Applications Open for SpinLab Accelerator Program

SpinLab The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the SpinLab team works to ensure that promising startups receive all the necessary resources as well as sufficient professional support for long-term success in the market. And the success proves the multiple award-winning accelerator right: numerous supported startups from Germany and abroad, hundreds of newly created jobs, and more than 150 million euros of invested venture capital by nationally and internationally renowned investors.

In addition to intensive coaching, the founding teams benefit from a top-class mentoring program and numerous contacts with renowned investors, established companies, and other successful founders. The startups can use modern, well-equipped co-working spaces on the world-renowned creative site of the Leipziger Baumwollspinnerei and get access to various technologies from partners. Even after the end of the program, the selected startups will be supported in personnel recruiting, can plan expansion via an international exchange program, and will have the opportunity to rent office space right next to SpinLab. Upon acceptance into the 6-month program, the founders have access to all offers free of charge and without participation.

Up to 15,000€ in free funding & acceleration grant up to 45,000€ Startups accepted into SpinLab Accelerator Program will receive 6,000€ in free funding to help cover their expenditures such as accommodation and travel costs to Leipzig while they are attending a hybrid program. Additionally, there are prizes available for the best pitch and most sustainable idea at the Investors Day, which can bring your total of free money up to 15,000€. On top of that, the acceleration grant can reach up to 45,000 euros. No equity, no shares, no fees.

Timeline for the next class

  • Next application deadline: 31.01.2023
  • Next program start date: 08.05.2023
  • Next program end date: 20.10.2023

For further information and to apply, please visit:
https://www.spinlab.co/apply-now

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...